e-Article
Efficacy of tofacitinib for the treatment of nail psoriasis: Two 52-week, randomized, controlled phase 3 studies in patients with moderate-to-severe plaque psoriasis
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
01909622